Advancell Advc001, Advc001 Phase 1, Esmo Congress 2026, Healthcare Technology, Mapmr Prostate Cancer (mcrpc), Metastatic Prostate Cancer Treatment, Psa50 Response Rate, Psma-targeted Therapy, Radioligand Therapy, Radiopharmaceutical Cancer Treatment, Targeted Alpha Therapy, Therapb Clinical Trial